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trol group served 32 pts without AS who underwent cardiac catheterization with passage 
of the AV. 
Results; 102 pts were randomised in group 1, 51 pts in group 2. Pts with or without retro- 
grade catheterization of the AVdid not differ in age (71±8 versus 69±10 years), mean 
pressure over the AV(51 ±18 versus 48 ±15 Hg) and AVA (0.69 ± 0.20 versus 0.72 -~-0.17 
cm2); whereas the incidence of.cerebral embolism was significantly higher in the group 
with retrograde catheterization than in those pts without passage of AV(22 versus 0, 
p=0.0006). 3 out of 22 pta with cerebral embolism as diagnosed by MRI had a neurologi- 
cal deficit. In the control group neither neurological deficits nor cerebral embolism were 
observed. 
Conelueions: Retrograde catheterization of valvular AS is associated with a consider- 
able risk of silent (22%) and clinically apparent (3%) cerebral embolism. Pts with AS who 
undergo only coronary angiography have a low risk of cerebral embolism. These findings 
have important clinical implications for the indication of retrograde catheterization of the 
AV for determining the severity of stenosis. 
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837-1 Fate of  Severe Mitral Regurgitation After Coronary 
Revascularization Alone 
B-Khanh Lam. A. Marc Gillinov, Brian Gdffin, Jeevanantham Rajeswaran, Eugene H. 
Btackstone, C/eve/and Clinic, C/eve/and, Ohio. 
Background: Traditionally, patients (pts) with moderately severe (3+) and severe (4+) 
mitral regurgitation (MR) undergo concomitant repair during coronary artery bypass graft- 
ing (CABG). The objectives of this study were to 1) contrast preoperative (preop) and 
introperative (inOR) MR, 2) characterize the pattern of MR postoperatively (postop), and 
3) to identify predictors of postop MR severity. 
Methods: From 1980 to 2000, 243 pts undergoing CABG alone had unrepaired 3+ and 
4+ MR by preop angiography or transthoracic echocardiogram (TTE). Mechanism of MR 
was ischemia in 205 (84%) pts, degenerative in 15 (6%), rheumatic in 4 (2%) and inde- 
terminate in 19 (8%). Right coronary artery (RCA) disease was present in 223 (92%) pts 
and left circumflex (LCx) disease in 188 (77%); 176 (72%) pts had prior myocardial inf- 
arction (MI), presenting acutely in 58 (25%). A total of 252 follow-up TTE were obtained 
from 127 (52%) pts. 
Results; Pre-CABG MR, assessed in 140 (58%) pts by inOR transesophageal echocar- 
diograms (TEE), was absent (0), mild (1+) or moderate (2+) in 119 (85%) pts and 3+ or 
4+ in 21 (15%). Post-CABG MR by inOR TEE in 56 (23%) pts was 0, 1+ or 2+ in 39 
(88%) and 3+ in 7 (12%). This inOR downgrading of MR led to non-repair in 155 (66%) 
pts; other reasons were apparent oversight in 42 (18%), discrepant preop MR grading in 
34 (14%) and hemodynamic instability in 6 (2%). Analysis of follow-up TTE for MR sever- 
ity over time showed that 76% of patients had 0 or 1+ MR early postop while 24% 
remained with a high grade of MR (3+/4+), Within the first two months, the proportion of 
pts with high grade (3+/4+) MR increased to 64% while that of milder MR (0/1+) 
decreased to 34% (P=-.02). A subsequent steady state of MR was observed to 14 years. 
Predictors of postop MR severity included RCA (P=.01) and LCx (P=.02) disease. InOR 
downgrading did not predict milder MR during follow-up. 
Conclusion: When inOR TEE downgrades MR, surgical decision-making should be 
based on preop assessment of MR. Early decreases in MR after CABG do not persist 
over time. High grade (3+t4+) MR is unlikely to resolve by coronary revascularization 
alone, particularly in patients with RCA and LCx disease. 
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837-2 Should CABG Patients With Mild or Moderate Aort ic  
Stenosis Undergo Concomitant Aortic Valve 
Replacement? A Decision Analysis Approach to the 
Surgica l  Dilemma 
William T, Smith. IV. T. B. Ferguson, Jr., Eric D. Peterson, Duke UniversityMedica/ 
Center, Durham, North Carolina. 
Background: Patients who need coronary artery bypass surgery (CABG) who also have 
asymptomatic, mild to moderate aortic stenosis (AS) may undergo isolated CABG or 
concomitant CABG and aortic valve replacement (CABG/AVR). This decision should ide- 
ally be individualized based on the patient's predicted long-term outcomes with each 
competing surgical strategy. 
Methods: We performed a Markov model decision analysis to compare the long-term 
quality adjusted life outcomes of patients with mild to moderate AS undergoing CABG, or 
CABG/AVR. Age-specific procedural morbidity and/or mortality risks with CABG, CABG/ 
AVR, or those with AVR following a prior CABG were based on the STS National Data- 
base (N >1 million) from 1995-2000. Likelihood of progression to symptomatic AS, prob- 
abilities for valve-related morbidity (stroke and bleeding risk), and age-adjusted mortality 
rates were obtained from available literature. 
Results: CABG mortality increased from 1.3% for patients <55 years old to 5.7% for 
patients >75; CABG/AVR mortality increased from 3.9 to 6.7%. Assuming a constant 
annual rate of progression of AS (7 mmHg/year), the optimal model decision was 
strongly affected by baseline patient age and aortic valve peak systolic gradient by 
echocardiography. For example, patients younger than 70 years old with a peak gradient 
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of over 26 mmHg had a longer average life expectancy with CABG/AVR than with CABG 
alone. In patients over age 70, however, CABG/AVR was preferred only as the baseline 
aortic valve gradient increased to approximately 50 mmHg. Sensitivity analysis demon- 
strated that the rate of AS progression influenced outcomes. With slow progression (2 
mmHg/year), CABG is favored for all ages of patients with AS gradients <50 mmHg; with 
rapid progression (14 mmHg/year), CABG/AVR is favored for all patients except those 
>80 years old with a valve gradient less than 25 mmHg. 
Conclusions,: This study provides clinicians with an empirical means of deciding which 
is the best procedure for patients with mild/moderate AS requiring bypass surgery based 
on their age, baseline aortic valve gradient, and rate of AS progression, 
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837-3 Constrictive Pericarditis in Patients With Coronary, 
Valvular, or Congenital Heart Disease: Outcome of 
Pericardiectomy Combined With Other Cardiac 
Operations 
David G. Cable, Hartzell V. Schaff, Thomas A, Orszu~ak, Jae K. Oh, Joseph A. Dearani, 
Charles J. Mullany, Richard C. Daly, Francisco J. Puga, Gordon K. Danielson, Mayo 
Clinic and Mayo Foundation, Rochester, Minnesota. 
Background - The safety of isolated pericardiectomy has improved in recent years (mor- 
tality of 6% in our most recent review), but little is known regarding outcome of the oper- 
ation when combined with other cardiac surgical procedures. 
Methods - From 1972 through 2000, 50 patients (mean age 61±15 years; 39 men) with 
other forms of heart disease had pericardiectomy for constrictive pericarditis; all had 
additional procedures including CABG in 28 (43% with IMA), valvular repair or replace- 
ment in 27 (tricuspid 55%, mitral 33%, and aortic 22%), and atrial septal repair in 4 pt. 
The etiology of constrictive pericarditis was idiopathic in 46%, postoperative (mean inter- 
val 6.1 years) in 38%, and secondary to mediastinal radiation in 14%. Advanced conges- 
tive heart failure (48% in NYHA Class IV) was present for an average 16 months 
preoperatively. 
Results - Nine pt died postoperatively, and the risk was independent of the etiology of 
constriction. Low cardiac output syndrome was the cause of death in 5 pt; hemorrhage 
accounted for one death. Excessive postoperative bleeding (mediastinal drainage 
>150cc/hr for six hours) occurred in 31% patients, and 7 pt (14%) required reoperation 
for bleeding. Use of antifibdnolytic agents including aprotinin did not reduce total blood 
transfusion requirements or transfusion of blood components. For all pt, probability of 
survival was 74_+6% at 1 year and 53+_9% at 5 years; survival was significantly reduced 
(P<0.001) in pt who had large transfusion requirements (_>50 units of blood and blood 
products, n=6). Postoperatively, 83% were in NYHA Class I or I1. 
Conclusions - The presence of associated cardiac disease increases morbidity and 
mortality o1 paricardiectomy for pt with constrictive pericarditis. Excessive bleeding 
occurs in approximately one-third of pt despite aggressive use of antifibriolytic drugs. 
Importantly, excessive bleeding after operation is associated with poor early and late sur- 
vival. 
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837-4 Echo/Doppler Evaluation of  137 Normal Aort ic  
Allografts: Comparison With New Generation Bileeflet 
Mechanical and StenUess Xenograft Prostheses 
Darrvl J. Burstow. Raffat Shameem, lan Smith, Joan Petch, Mark F. O'Brien, The Prince 
Chades Hospital Bdsbane, Austra/ia. 
Background: A major advantage of the normal allograft prosthesis (A AIIo) is said to be 
superior hemodynamic performance. Recently, new generation mechanical and tissue 
prostheses with improved hemodynamios have become available. The aim of the current 
study was to establish the normal values for Doppler hemodynamic parameters for AAUo 
and compare findings with previously obtained data for the ATS mechanical and Cryolife 
O'Brien (CLOB) stentless xenograft prostheses. Method: Utilizing our data base, 137 
patients were identified who had undergone echo/Doppler evaluation less than 12 
months following AAllo implantation and had < grade 1/4 aortic regurgitation(AR). 
Reaults: A selection of data is provided below and is presented as median and inter- 
quadile ranges. The Mann-Whitney test was used for comparison of Doppler parameters. 
P value was <0.05 for all AAllo Doppler parameters compared with ediuvalent CLOB and 
ATS values while p was <0.05 for all CLOB values compared with ATS except for EOA 
and EONBSA at the 27mm valve size. DPI = Dimensionless Performance Index. EOA = 
Effective Orifice Area. BSA = Body Surface Area. Con¢luelona: 1. This study estab- 
lishes normal reference ranges for AAIIo Doppler data. 2. Hemodynamic performance of 
hallo is still superior to new generation mechanical and tissue prostheses.3. CLOB valve 
has superior hemodynamics to the ATS valve especially at the smaller valve sizes. 
Doppler Parameters 
Valve size/type AAIIo CLOB ATS AAIIo CLOB ATS AAIIo CLOB ATS 
23mm 23mm 23ram 25ram 25ram 25ram 27mm 27mm 27mm 
Peak velocity 1.8 2.5 2.5 1.5 2.2 2.3 1.5 2 2.2 
(V2) m/s 1,6-1.9 2.0-2.7 2.3-2.7 1.3-1.7 2.0-2.5 2.1-2.6 1.4-1.7 1.8-2.3 1.9-2.3 
Mean Gradient 6 11 14 5 10 12 5 8 10 
mmHg 4-8 9-15 11-16 4-6 7-13 11-15 4-7 6-10 8-12 
DPI (V2/LVOT 0.68 0.51 0.39 0.68 0.5 0.42 0.65 0.52 0.43 
velocity) .55-.81 ,40-.56 .33-.44 .69-.76 .44-.58 .36-.47 .54-.73 .48-.59 .39-.50 
EOA cm2 2.7 1.7 1.6 3.2 2.2 2.1 3.5 2.5 2.6 
2.2-3.1 1.6-1.9 1.5-1.9 2.9-3.5 1.9-2.5 1.8-2.3 2.7-4.0 2.1-2.8 2.1-3 
EONBSA cm2/ 1.4 1.1 1 1.6 1.2 1.1 1.8 1.4 1.3 
m2 1.3-1.7 1.0-1,2 0.8-1,1 1.5-1.8 1.0-1.4 0.9-1.3 1.4-2.0 1.1-1.5 1.0-t.5 
